Echinacea is an herbal medicine that is widely used as an immunomodulator and in the
prevention and treatment of colds and minor infections. Although alkamides found in
medicinal preparations of Echinacea angustifolia and Echinacea purpurea have been shown to be present in blood after oral ingestion [1,2], their presence
or absence in the milk of lactating women is unknown. The concept of treating infants
by medication of the lactating mother is widely followed in naturopathy, as this gives
a means of delivering the required low doses to the infant with the added advantage
of having been 'filtered' by the mother. In alleopathic medicine, absorption of compounds
into breast milk is also important from the perspective of safety of the infant to
medications taken by the mother.
In this study, we have examined human breast milk from a 35 year old volunteer at
six different time points after ingestion of four Echinacea Premium tablets. Each
tablet was comprised of the equivalent of 675mg of Echinacea purpurea root and 600mg of Echinacea angustifolia root prepared from the dried ethanolic extracts of the two Echinacea species. The volunteer ingested 13.1mg of the N-isobutyldodeca-2E,4E,8Z,10E/Z-tetraenamide
alkamides.
The alkamides were found to be present between 1 and 4 hours after ingestion of the
Echinacea Premium tablets. Concentrations in breast milk were similar to those previously
reported in plasma after ingestion of a similar dose and tablet preparation [1]. This
shows that alkamides are present in human milk after ingestion of Echinacea preparations
and are passed to the infant during feeding.
References: 1. Matthias, A. et al. (2005) Life Sci 77:2018–2029.
2. Woelkart, K. et al. (2005)J Clin Pharmacol 45: 683–689.
